CI has been all over the place this year. Just looking at the price swings since last summer up to 330 at one point, down to 263 not long ago, and now around 288 you can tell this isn’t the sort of slow, steady healthcare stock some people expect. The volatility says a lot about where investor confidence is right now.
I'm leaning bullish here, with a target of 316.00 over the next couple months. The biggest driver is that the recent pullback from last fall’s highs has mostly been about broad sector rotation and not something fundamentally broken at Cigna. Their core insurance business is still printing cash, and pharmacy benefits haven’t slowed as much as the bears were hoping. If they can show any decent growth or margin improvement in the next earnings season, I think we’ll see a snapback.
It’s not all smooth sailing. Reimbursement pressure and policy tweaks are always lurking, and any surprise from regulators could knock this back down quick. That’s the main risk I see if guidance gets trimmed, the stock could hang out in the 270s for a while. But if management holds the line and posts a clean quarter, money will rotate back into defensive names like this.
Main thing I’m watching is the next earnings call. If CI puts up solid numbers and doesn’t guide down, that could be the green light for a run back toward 316.00. Not a moonshot, but the setup looks solid for a 10 percent move from here.
